| Drug Name |
Interferon beta-1b |
| Drug ID |
BADD_D01170 |
| Description |
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD |
| Indications and Usage |
Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks. |
| Marketing Status |
approved |
| ATC Code |
L03AB08 |
| DrugBank ID |
DB00068
|
| KEGG ID |
D00746
|
| MeSH ID |
D000068576
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0CQ2O
|
| NDC Product Code |
0078-0569; 50419-524 |
| UNII |
TTD90R31WZ
|
| Synonyms |
Interferon beta-1b | Beta-IFN-1b | Ser(17) IFN-beta | Interferon Beta, Serine(17) | Serine(17) Interferon Beta | Interferon beta 1b | IFN-Beta Ser | Interferon Beta, Ser(17) | Betaseron | Beta-Seron | Beta Seron | Extavia | Betaferon |
